Posaconazole Intravenous and Oral in Children With Invasive Fungal Infection
This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants